background
pig
implic
mix
reservoir
gener
new
pandem
influenza
strain
control
swine
influenza
veterinari
public
health
signific
unlik
human
influenza
vaccin
strain
use
commerci
avail
swine
influenza
vaccin
regularli
replac
make
vaccin
provid
limit
protect
antigen
divers
virus
therefor
necessari
develop
broadli
protect
swine
influenza
vaccin
efficaci
homolog
heterolog
viru
infect
studi
two
form
dna
vaccin
construct
one
made
fuse
consensu
mha
repres
major
ha
sequenc
swine
influenza
virus
anoth
made
fuse
conserv
ctl
epitop
consensu
mnha
protect
efficaci
homolog
heterolog
challeng
test
result
balbc
mice
immun
twice
particlemedi
epiderm
deliveri
gene
gun
two
dna
vaccin
shown
two
vaccin
elicit
substanti
antibodi
respons
mnha
induc
signific
cellmedi
immun
respons
mha
two
strain
repres
differ
evolut
antigen
cluster
use
challeng
vaccineimmun
mice
homosubtyp
challeng
result
indic
dna
vaccin
prevent
homosubtyp
viru
infect
complet
vaccin
heterolog
protect
efficaci
test
challeng
swine
influenza
viru
reassort
pandem
strain
found
mnha
reduc
lung
viral
titer
significantli
challeng
group
histopatholog
observ
show
obviou
reduct
lung
pathogenesi
compar
mha
control
group
combin
util
consensu
ha
conserv
ctl
epitop
confer
complet
partial
protect
homolog
heterolog
challeng
respect
mous
model
may
provid
basi
develop
univers
swine
influenza
vaccin
swine
influenza
viru
siv
member
genu
influenza
viru
famili
orthomyxovirida
common
import
caus
pathogen
involv
porcin
respiratori
diseas
mortal
sivinfect
pig
low
morbid
may
approach
clinic
sign
swine
influenza
includ
high
fever
lethargi
anorexia
cough
labor
breath
nasal
discharg
synergist
secondari
infect
opportunist
organ
may
increas
sever
clinic
diseas
beyond
veterinari
implic
influenza
viru
infect
pig
also
present
import
public
health
risk
sinc
pig
express
sialic
acid
receptor
mammalian
avian
strain
influenza
virus
tracheal
epitheli
cell
could
potenti
serv
mix
vessel
gener
new
reassort
strain
influenza
virus
pandem
capac
recent
emerg
pandem
result
death
exampl
http
indexhtml
genet
analys
reveal
pandem
influenza
viru
tripl
reassort
multipl
strain
virus
circul
north
america
eurasia
swine
popul
therefor
sivinfect
control
would
benefit
reduc
econom
loss
swine
industri
human
health
vaccin
consid
effect
method
control
siv
current
commerci
avail
swine
influenza
vaccin
adjuv
wholeviru
kill
vaccin
although
vaccin
reduc
sever
diseas
extent
viru
shed
pig
challeng
provid
consist
protect
infect
vaccin
function
target
surfac
glycoprotein
hemagglutinin
ha
variabl
influenza
viru
antigen
protect
efficaci
depend
antigen
match
degre
vaccin
circul
strain
howev
influenza
virus
continu
evolv
increas
mutat
epitop
antigen
drift
reconstitut
genom
strain
antigen
shift
increas
incid
avianlik
humanlik
siv
reassort
exhibit
great
genet
divers
thu
antigen
divers
classic
siv
document
result
antigen
mismatch
vaccin
circul
strain
addit
domin
subtyp
circul
swine
popul
worldwid
ie
develop
multipl
genet
cluster
base
phylogenet
analysi
ha
gene
previou
studi
demonstr
virus
differ
cluster
show
limit
crossreact
suggest
genet
antigen
heterogen
within
subtyp
may
reduc
vaccin
effect
vaccin
induc
broad
protect
immun
divers
siv
cluster
even
subtyp
limit
spread
virus
pig
human
especi
pandem
strain
therefor
need
consensu
differ
strain
within
one
subtyp
previous
studi
elicit
crossclust
protect
ha
induc
predomin
subtypespecif
humor
immun
respons
contrast
conserv
viral
antigen
intern
np
gener
heterosubtyp
immun
protect
divers
viru
strain
subtyp
unlik
ha
npinduc
cellmedi
immun
respons
prevent
infect
reduc
sever
ill
acceler
viru
clearanc
reason
propos
combin
util
consensu
ha
conserv
viral
protein
confer
complet
protect
homosubtyp
least
partial
heterosubtyp
challeng
present
studi
two
type
swine
influenza
dna
vaccin
construct
fuse
matrix
ectodomain
consensu
ha
subtyp
siv
mha
mean
ha
fuse
conserv
ctl
epitop
consensu
ha
mnha
mean
ha
protect
efficaci
broad
diverg
siv
challeng
test
mice
dna
vaccin
elicit
haspecif
antibodi
increas
express
level
ctl
epitop
consensu
ha
gene
optim
codon
usag
rna
structur
gc
content
codonoptim
consensu
ha
link
clone
eukaryot
express
vector
without
gener
two
dna
vaccin
figur
nucleotid
sequenc
dna
vaccin
plasmid
transfect
human
embryon
kidney
hek
cell
express
chimer
protein
confirm
indirect
immunofluoresc
assay
ifa
ifa
show
ha
gene
express
vitro
data
shown
two
dna
vaccin
well
empti
vector
coat
gold
particl
deliv
skin
gene
gun
humor
immun
analyz
detect
presenc
antigenspecif
antibodi
seen
figur
construct
evok
substanti
haspecif
igg
respons
booster
inject
suggest
two
vaccin
adequ
deliv
express
mice
signific
differ
serum
igg
antibodi
level
observ
mha
mnha
group
p
indic
addit
length
ctl
epitop
influenc
vaccin
antibodyinduc
abil
significantli
antibodi
titer
lower
ha
p
surpris
contain
amino
acid
report
less
immunogen
ha
hi
assay
perform
homosubtyp
heterosubtyp
viru
assess
abil
induc
relev
crossreact
function
antibodi
detail
tabl
vaccin
immun
group
develop
hi
antibodi
homolog
virus
induc
low
level
hi
antibodi
heterolog
virus
abil
clt
epitopecontain
vaccin
mnha
induc
cellular
immun
respons
determin
elispot
assay
synthes
peptid
use
restimul
splenocyt
isol
mice
group
result
show
restimul
number
activ
secret
cell
mice
immun
mnha
significantli
higher
mice
immun
mha
empti
vector
p
figur
mha
mnha
vaccin
confer
complet
protect
homolog
challeng
mnha
show
signific
crossprotect
heterolog
challeng
mha
previou
studi
indic
wild
type
strain
replic
poorli
mice
unpublish
data
make
viru
suitabl
vaccin
efficaci
assess
vivo
construct
recombin
viru
use
revers
genet
contain
ha
na
intern
protein
balbc
mice
infect
intranas
two
homolog
strain
belong
differ
cluster
within
subtyp
day
last
immun
mice
lung
taken
day
post
infect
viru
titrat
histopatholog
chang
observ
result
demonstr
detect
viru
load
vaccineimmun
mice
empti
vector
control
group
show
high
lung
viral
titer
figur
addit
histopatholog
observ
show
obviou
histopatholog
chang
vaccin
mice
contrast
empti
vector
control
group
exhibit
histopatholog
damag
includ
dropout
mucou
epithelium
cell
interstiti
edema
hyperemia
hemorrhag
inflammatori
cell
infiltr
figur
sinc
conserv
differ
subtyp
influenza
virus
hypothes
dna
vaccin
confer
partial
protect
heterosubtyp
challeng
test
vaccin
protect
abil
studi
mice
challeng
siv
also
circul
swine
popul
worldwid
immun
mice
challeng
heterolog
respect
lung
viral
titer
determin
patholog
analysi
perform
describ
result
indic
mice
vaccin
mha
detect
viru
level
although
show
reduct
mean
viral
titer
challeng
group
compar
vector
control
reduct
reach
signific
p
group
p
group
figur
histopatholog
analysi
exhibit
correspond
result
ie
mice
mha
group
lung
patholog
almost
sever
vector
inocul
group
mnha
group
although
mice
also
exhibit
detect
glyglyglyglyserglyglyglyglyserglyglyglyglys
linker
viru
shed
mean
viral
titer
significantli
reduc
group
compar
vectorimmun
control
p
show
averag
viral
titer
reduct
log
respect
figur
expect
patholog
damag
mice
lung
mnha
group
less
pronounc
mha
vector
control
group
moder
histopatholog
lesion
mainli
vascular
congest
variou
degre
hemorrhag
observ
figur
collect
find
indic
consensu
ha
combin
elicit
crossclust
immun
ctl
respons
contribut
control
clearanc
infect
reduc
pathogenesi
although
virus
highli
continu
variabl
antigen
drift
shift
influenza
vaccineprevent
diseas
convent
inactiv
human
influenza
vaccin
updat
annual
world
health
organizationrecommend
influenza
b
strain
order
antigen
match
virus
predict
like
caus
next
epidem
unlik
human
influenza
vaccin
strain
use
swine
influenza
vaccin
prepar
regularli
replac
make
vaccin
provid
limit
protect
antigen
divers
siv
univers
vaccin
design
base
conserv
viral
protein
confer
broad
protect
attract
solut
counter
featur
highli
variabl
human
also
swine
influenza
virus
mani
studi
develop
univers
vaccin
human
influenza
wherea
broadli
respons
swine
influenza
vaccin
knowledg
report
viru
envelop
glycoprotein
ha
abund
surfac
protein
antibodi
ha
provid
protect
block
viru
attach
entri
studi
sever
group
demonstr
antivir
efficaci
consensu
ha
intrasubtyp
univers
vaccin
studi
chen
et
al
show
consensu
habas
dna
vaccin
elicit
moder
neutral
activ
toward
clade
clade
virus
provid
complet
albeit
signific
protect
clade
viru
suggest
consensu
ha
alon
may
enough
induc
complet
protect
strain
within
one
subtyp
much
less
heterosubtyp
strain
howev
ideal
univers
vaccin
capabl
induc
protect
homosubtyp
heterosubtyp
challeng
end
link
ctlinduc
epitop
consensu
ha
construct
univers
swine
influenza
vaccin
reason
chose
highli
conserv
among
differ
siv
strain
even
conserv
among
human
avian
swine
figur
protect
mice
homolog
heterolog
challeng
mice
lung
viral
titer
day
challeng
determin
egg
initi
dilut
phosphatebuff
salin
express
eid
ml
limit
viru
detect
influenza
strain
tabl
ad
view
abil
broaden
protect
scope
vaccin
induc
vigor
ctl
respons
studi
indic
specif
ctl
provid
level
crossprotect
antigen
distinct
virus
subtyp
also
differ
subtyp
previous
shown
evolv
independ
lineag
base
phylogenet
analysi
ha
gene
see
whether
two
strain
antigen
distinct
crosshi
assay
perform
use
antiserum
found
titer
crossreact
hi
antibodi
significantli
lower
hi
antibodi
p
data
shown
thu
suggest
belong
differ
antigen
cluster
result
present
studi
demontr
mha
mnha
vaccin
provid
complet
protect
two
virus
challeng
crossclust
protect
therefor
suggest
mnha
mha
induc
immun
respons
partial
protect
heterolog
influenza
infect
suggest
echanc
tcell
mediat
respons
requir
homolog
protect
result
also
confirm
ctl
respons
play
import
role
heterolog
protect
mean
strengthen
ctl
respons
promis
way
univers
influenza
vaccin
develop
establish
pandem
pathogen
readili
transmit
pig
although
new
viru
consid
postpandem
possibl
recombin
influenza
virus
pig
yield
novel
potenti
epidem
pandem
strain
still
exist
studi
mice
partial
protect
reassort
pandem
viru
challeng
immun
mnha
vaccin
immun
inhibit
pulmonari
viral
replic
significantli
mice
thu
could
acceler
viru
clearanc
reduc
potenti
transmiss
risk
recombin
although
heterolog
protect
elicit
dna
vaccin
complet
methodolog
larg
potenti
improv
present
studi
lay
foundat
univers
swine
influenza
vaccin
develop
call
investig
heterolog
immun
respons
enhanc
addit
molecular
adjuv
andor
copi
conserv
viral
protein
encod
gene
usag
dnaprim
proteinvirusboost
immun
schedul
previou
studi
conduct
heinen
et
al
construct
dna
vaccin
contain
full
length
np
gene
ha
encod
gene
includ
data
show
dna
vaccin
produc
enhanc
diseas
challeng
although
mechan
underli
unclear
think
ha
may
play
role
discrep
result
heinen
et
al
anoth
possibl
reason
taken
consider
gene
gun
immun
induc
strong
immun
respons
convent
needl
inject
method
use
heinen
et
al
studi
necessari
studi
whether
dna
vaccin
develop
confer
protect
pig
model
also
would
interest
studi
ha
protein
influenc
vaccin
efficaci
combin
util
consensu
ha
conserv
ctl
epitop
confer
complet
partial
protect
homolog
heterolog
challeng
respect
mous
model
may
provid
promis
strategi
univers
swine
influenza
vaccin
develop
virus
cell
mice
medicin
south
china
agricultur
univers
contain
surfac
glycoprotein
intern
protein
prepar
use
revers
genet
describ
virus
propag
allanto
caviti
old
spf
embryon
chicken
egg
store
use
fiftyperc
embryo
infecti
dose
eid
titer
determin
serial
titrat
embryo
calcul
method
reed
muench
hek
cell
maintain
dulbecco
modifi
eagl
medium
dmem
sigma
supplement
fetal
bovin
serum
humidifi
co
atmospher
spf
femal
balbc
mice
week
age
purchas
shanghai
slac
laboratori
anim
co
ltd
maintain
free
access
steril
food
water
anim
studi
conduct
accord
ethic
guidelin
approv
ethic
committe
shanghai
veterinari
research
institut
chines
academi
agricultur
scienc
total
ha
sequenc
fulllength
subtyp
siv
respect
download
genbank
databas
align
megalign
program
supplement
dnastar
packag
dnastar
madison
wi
consensu
sequenc
creat
base
common
amino
acid
posit
align
consensu
sequenc
gener
first
amino
acid
select
motif
codon
consensu
ha
well
immunodomin
cytotox
lymphocyt
ctl
epitop
np
protein
tyqrtralv
optim
mammalian
express
synthes
genscript
corpor
nanj
china
chimer
orf
encod
ctl
epitop
consensu
ha
pcramplifi
introduc
sma
nhe
restrict
site
ligat
pcagg
vector
control
cytomegaloviru
cmv
enhanc
chicken
promot
design
mnha
similarli
mha
design
construct
except
ctl
epitop
omit
ntermin
end
consensu
ha
figur
recombin
plasmid
identifi
nucleotid
sequenc
propag
e
coli
bacteria
purifi
use
mega
purif
kit
qiagen
valencia
ca
vitro
transfect
well
vivo
anim
immun
final
dna
prepar
resuspend
nucleasefre
water
store
use
hek
cell
seed
plate
transfect
confluenc
mha
mnha
empti
vector
use
lipofectamin
transfect
reagent
invitrogen
recommend
manufactur
h
transfect
cell
scrape
cultur
plate
wash
pb
spot
onto
glass
slide
air
dri
fix
prechil
aceton
upon
remov
residu
solvent
slide
cell
incub
ha
polyclon
antibodi
h
secondari
alexa
fluor
goat
antimous
igg
antibodi
use
detect
primari
antibodi
fluoresc
imag
scan
use
invert
microscop
sampl
mount
glycerol
gene
gun
immun
perform
previous
describ
mice
receiv
two
nonoverlap
abdomin
deliveri
antigen
encod
plasmidor
empti
vectorco
gold
bead
shave
skin
interv
shot
dna
immobil
onto
mg
gold
particl
deliv
helium
discharg
pressur
psi
helio
gene
gun
biorad
test
group
contain
mice
experi
organ
follow
mice
group
use
complet
elispot
assay
day
post
immun
left
mice
group
divid
subgroup
compris
mice
intranas
challeng
eid
two
two
strain
respect
day
final
immun
serum
sampl
collect
orbit
bleed
day
post
last
immun
ha
antibodi
titer
measur
use
indirect
elisa
elisa
plate
coat
overnight
synthet
peptid
inactiv
carbon
buffer
ph
block
nonfat
milk
h
seri
twofold
dilut
sera
start
dilut
ha
incub
h
follow
three
wash
pbst
hrpconjug
goat
antimous
igg
zhongshan
biotechnolog
co
ltd
beij
china
benzidin
tmb
use
haspecif
antibodi
detect
color
develop
respect
result
optic
densiti
od
nm
determin
plate
reader
reaction
stop
h
hi
assay
perform
use
chicken
red
blood
cell
rbc
ha
unit
homolog
heterolog
viru
receptordestroy
enzym
rde
sigma
treat
serum
previous
describ
reciproc
highest
dilut
serum
gave
complet
inhibit
hemagglutin
consid
hi
titer
assay
perform
triplic
titer
less
start
serum
dilut
assign
serum
sampl
inhibit
hemagglutin
elispot
assay
perform
use
mous
elispot
kit
follow
method
recommend
manufactur
dakew
biotech
pr
china
briefli
singlecel
suspens
freshli
isol
spleen
lymphocyt
seed
plate
well
precoat
monoclon
antibodi
cell
stimul
synthes
peptid
final
concentr
humidifi
incub
co
phytohemagglutinin
pha
medium
alon
use
posit
neg
control
respect
h
cultur
plate
wash
incub
h
biotinyl
antimous
antibodi
streptavidinhorseradish
peroxidas
ad
spot
develop
ethylcarbazol
aec
count
use
autom
elispot
reader
result
express
spotform
cell
sfc
per
million
cell
day
postinfect
mice
group
sacrif
collect
lung
viru
titrat
patholog
examin
determin
protect
abil
dna
vaccin
viru
titrat
whole
lung
homogen
ml
steril
phosphatebuff
salin
pb
contain
mgml
streptomycin
iuml
penicillin
homogen
dilut
serial
centrifug
inocul
embryon
chicken
egg
infect
within
individu
egg
confirm
use
standard
hemagglutin
assay
viral
titer
determin
method
reed
muench
lung
tissu
histopatholog
section
made
describ
elsewher
briefli
remov
lung
fix
neutral
buffer
formalin
dehydr
embed
paraffin
five
micromet
section
cut
stain
hematoxylin
eosin
h
e
review
histopatholog
chang
